Table 3 Analysis of variance
From: Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment
Global health EORTC QLQ-C30 | EQ-5D Index | EQ VAS | |||
|---|---|---|---|---|---|
| Â | Subgroup | Mean difference (SE) | p-value | Mean difference (SE) | p-value |
| Â | Moderate-large deterioration (n = 23) | -0.14 (0.07) | .228 | -13.88 (2.65)* | .000 |
No change | Small deterioration (n = 14) | 0.01 (0.05) | 1.000 | -5.78 (3.44) | .470 |
(n = 55) | Small improvement (n = 28) | 0.02 (0.04) | .984 | 5.37 (1.93) | .054 |
| Â | Moderate-large improvement (n = 72) | 0.13 (0.04)* | 0.006 | 11.38 (1.97)* | .000 |